相关实验视频

Updated: May 12, 2025

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.3K

使用CD138选择的骨髓细胞产生人类免疫球蛋白轻链的异构基因组

P Zhou1, X Ma1, S Scalia1

  • 1Tufts Medicine Myeloma and Amyloid Program, USA.

Biochemistry and biophysics reports
|May 7, 2025
PubMed
概括

异构体 (HH) 技术成功地产生了人类轻链 (FLC),从多发性骨髓瘤和多克隆性骨髓病患者中产生克隆. 这些产生FLC的HH克隆为研究FLC行为和开发新疗法提供了宝贵的工具.

关键词:
在CD138中,CD138是关于CD138的.异种混合体瘤 (heterohybridomas) 是一种异种混合体瘤.免疫球蛋白轻链 免疫球蛋白轻链血细胞是一种血细胞.

更多相关视频

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

18.3K
Generation of Murine Monoclonal Antibodies by Hybridoma Technology09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.3K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K